Skip to content
  • Tuesday, 30 June 2026
  • 1:08 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • The Eliquis Patent Cliff: A $14.2 Billion Revenue Erosion Set to Reshape Pharmaceutical Giants
Pharmaceutical R&D

The Eliquis Patent Cliff: A $14.2 Billion Revenue Erosion Set to Reshape Pharmaceutical Giants

Teuku Ryan May 27, 2026 0

The impending loss of exclusivity for Eliquis (apixaban) is poised to become one of the most significant revenue-generating events in…

Read More
Pharmaceutical R&D

Eliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic Proportions

Teuku Ryan May 1, 2026 0

The pharmaceutical industry is bracing for one of the most significant patent cliff events in its history as Eliquis, the…

Read More
Penn State Researchers Resolve Decades-Old Muon Mystery Validating the Standard Model and Diminishing Hopes for a Fifth Force of NatureBeyond PD-1: The drugs reshaping cancer treatment at ASCO 2026Virtual Heart Replicas Revolutionize Cardiac Ablation Procedures, Offering Unprecedented Personalization and PrecisionBreakthrough Combination Therapy Offers New Hope for Acute Myelogenous Leukemia Patients by Dismantling Differentiation Barriers
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveHigh-Dimensional Topological Structures Discovered in Entangled Photons Offer New Framework for Quantum Information StabilityWater-in-Diesel Emulsion Technology Offers Significant Emissions Reduction Potential Without Engine Modification
The Genetic Legacy of Paternal Aging: How Intra-Testicular Selection Drives Disease-Causing Mutations in SpermPens to pills: what oral GLP-1s change at the benchArc Protein Identified as Key Driver in the Spread of Toxic Tau Proteins in Alzheimer’s DiseaseTalawar Therapeutics and JATT II Acquisition Complete Business Combination to Advance Novel Immunology Therapeutics
YOU MAY HAVE MISSED
Stem Cell & Regenerative Medicine
The Genetic Legacy of Paternal Aging: How Intra-Testicular Selection Drives Disease-Causing Mutations in Sperm
Dwi Wanna Jun 30, 2026
Laboratory Automation & Robotics
Pens to pills: what oral GLP-1s change at the bench
Lana Keisha Jun 30, 2026
Neuroscience & Brain Research
Arc Protein Identified as Key Driver in the Spread of Toxic Tau Proteins in Alzheimer’s Disease
Rifan Muazin Jun 30, 2026
Pharmaceutical R&D
Talawar Therapeutics and JATT II Acquisition Complete Business Combination to Advance Novel Immunology Therapeutics
Teuku Ryan Jun 30, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ